Skip to main content

Duration of Follow Up for New Molecular Entities Approved in 2022: First Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Medical Product
new molecular entities (NMEs)
Description

In this report, we characterized dispensing and administration patterns of 37 New Molecular Entities (NMEs) approved from January 1, 2022 through December 31, 2022, stratified by age and sex in the Sentinel Distributed Database (SDD).

The study period includes data from January 1, 2022 to November 14, 2024 . We distributed this request to five Sentinel Data Partners on November 14, 2024.

Deliverables (1)
Sentinel Modular Program Report: Duration of Follow Up for New Molecular Entities Approved in 2022: First Descriptive Analysis
Additional Details
FDA Center
CDER
Time Period
January 1, 2022 - May 31, 2024
Analysis Type
Descriptive
Population / Cohort
All individuals
Data Sources
Sentinel Distributed Database (SDD)